Prospective Study for Symptomatic Relief of ET With Cala Therapy
Public ClinicalTrials.gov record NCT03597100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Study for Symptomatic Relief of Essential Tremor With Cala Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prospective, multi-center, single-arm, non-significant risk study designed to evaluate the Cala TWO device. Subjects will be screened for eligibility and fitted with a Cala TWO device. Subjects will wear the device at home for a period of 3 months, during which they will be asked to stimulate their dominant hand twice a day. The stimulation amplitude will be based on each subject's stimulation threshold. Subjects will have in clinic assessments at enrollment, month 1 and 3.
Study identification
- NCT ID
- NCT03597100
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 263 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 14, 2018 (Actual)
- Primary completion
- May 29, 2019 (Actual)
- Completion
- May 29, 2019 (Actual)
- Last update posted
- Oct 12, 2023
2018 – 2019
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute (Dignity Health) | Phoenix | Arizona | 85013 | — |
| USC | Los Angeles | California | 90033 | — |
| Parkinson's Institute and Clinical Center | Mountain View | California | 94040 | — |
| University of California San Francisco | San Francisco | California | 94143 | — |
| Pacific Neuroscience Institute | Santa Monica | California | 90404 | — |
| Rocky Mountain Movement Disorders Center | Denver | Colorado | 80113 | — |
| Hospital for Special Care | New Britain | Connecticut | 06053 | — |
| Medstar Gerogetown Health Institute | Georgetown | District of Columbia | 20007 | — |
| Parkinson's Center | Boca Raton | Florida | 33486 | — |
| USF | Tampa | Florida | 33612 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Kansas University Medical Center | Kansas City | Kansas | 66160 | — |
| Kaiser Mid-Atlantic Group | Largo | Maryland | 20774 | — |
| Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Henry Ford Health System | West Bloomfield | Michigan | 48322 | — |
| Mayo Clinic | Rochester | Minnesota | 55902 | — |
| Advanced Neurology Specialists | Great Falls | Montana | 95405 | — |
| Parkinson's Disease and Movement Disorders Center of Long Island | Long Island City | New York | 10017 | — |
| Mount Sinai & Beth Isreal | New York | New York | 10003 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Wake Forest | Raleigh | North Carolina | 27157 | — |
| River Hills Neuroscience | Cincinnati | Ohio | 45255 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| University Of Pennsylvania Medicine | Philadelphia | Pennsylvania | 19104 | — |
| Jefferson University | Philadelphia | Pennsylvania | 19144 | — |
| University of Texas Southwestern | Dallas | Texas | 75390 | — |
| Texas Movement Disorder Specialist | Georgetown | Texas | 78628 | — |
| Houston Methodist | Houston | Texas | 77030 | — |
| Central Texas Neurology Consultants | Round Rock | Texas | 78681 | — |
| Swedish | Bellevue | Washington | 98004 | — |
| EvergreenHealth Medical Center | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03597100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03597100 live on ClinicalTrials.gov.